Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland.
The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings
Agenda (Overview)
Approval of the Annual Report, Annual Financial Statements and the Consolidated Financial Statements 2024
Appropriation of the Annual Result and Offset of Deficit
Consultative Vote on the Compensation Report 2024
Discharge of the Members of the Board of Directors and of the Executive Management from Liability for the Financial Year 2024
Conditional Capital for Employee Participations and Amendment to the Articles of Incorporation
Election of a new Member & Re-election of two Members of the Board of Directors and of the Chairman of the Board
Re-election of the Members of the Nomination & Compensation Committee
Approval of the Compensation of the Members of the Board of Directors
Approval of the Compensation of the Members of the Executive Management
Re-election of the Statutory Auditors
Re-election of the Independent Proxy